4th Affiliated Hospital, School of Medicine, Zhejiang University
Jinhua, Zhejiang, 322000, China
Location status: Recruiting
NCT Number: NCT07372326
This study aims to explore the application effect of Ziwu Liuzhu electronic moxibustion combined with auricular points on constipation in stroke patients through clinical controlled trials, as well as the advantages over using electronic moxibustion alone.
Interested in participating?
Request Info30 year–80 year
All sexes
Interventional
Not applicable
Jinhua, Zhejiang, 322000, China
Location status: Recruiting
This study aims to explore the application effect of Ziwu Liuzhu electronic moxibustion combined with auricular points on constipation in stroke patients through clinical controlled trials, as well as the advantages over using electronic moxibustion alone. It provides new explorations, new ideas and new methods for the effective clinical care of constipation in stroke patients, and offers theoretical and guiding basis for the application and promotion of electronic moxibustion.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Dropout criteria and termination criteria:
Note: For any patient meeting any of the above criteria 1, they will be handled as a dropout case.
The intervention group B added electronic moxibustion to the treatment of group A: Assist the patient to assume the supine position, aim at the moxibustion areas around the navel (Shenque, Guanyuan, Qihai, Xiaowan, Tianqiu), and use electronic moxibustion therapy (Production License No. 20180137 of Su Food and Drug Administration). The distance from the skin is 5 to 10 cm, and each area is moxibustion for 30 minutes. During the moxibustion process, ask the patient if there is any discomfort, observe the patient's skin condition, and assist the patient to put on clothes and take a comfortable lying position after the treatment.
The intervention group C patients were given electronic moxibustion therapy based on the theory of Ziwen Liuzhun (midnight to dawn) under the premise of the control group B. According to the theory of Ziwen Liuzhun, the hour of Ba (05:00 - 07:00) is the time when the large intestine meridian is in charge, and at this time, the blood and qi of the large intestine are abundant, which is most conducive to excretion. The hour of Chen (07:00 - 09:00) is the time when the stomach meridian is in charge, and at this time, the qi of the stomach meridian is vigorous, which is most conducive to regulating the connection between the stomach and the spleen. Based on the specific conditions of each patient, moxibustion treatment was given at the corresponding hour. The specific moxibustion therapy was the same as that of the control group. The intervention lasted for 2 weeks.
Time frame: The timing of the intervention starts from the moment it begins until the first successful defecation occurs, and is recorded in hours (h).
Time frame: An assessment was conducted before the experimental intervention, on the 7th day of the intervention, and after the completion of the intervention.
CCSis mainly used to assess the severity of constipation and has good reliability and validity. It is widely used in clinical trial evaluations. The items involved all match the items of the Rome IV standard. Except for one item with a score range of 0-7, the score range of all other items is 0-4. The higher the total score, the more severe the constipation.
Contact information is provided by the study sponsor or research team.
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06801184
Colonic Diseases, Colonic Diseases, Functional
Lyon, France
View Trial DetailsNCT06402968
Brain Diseases, Cardiovascular Diseases
Irvine, California, United States
View Trial DetailsNCT07545772
Colonic Diseases, Colonic Diseases, Functional
Mesa, Arizona, United States
View Trial DetailsNCT07712198
Atrophy, Brain Diseases
Trabzon, Turkey (Türkiye)
View Trial Details